Longevity with Type 2 Diabetes:
What the Evidence Actually Shows

How Type 2 Diabetes Accelerates Aging

Type 2 diabetes is more than high blood sugar. Insulin resistance in muscle is considered its primary defect,¹ and years of high glucose and insulin take a toll on blood vessels, nerves, kidneys and eyes.

In a meta-analysis of 102 prospective studies, diabetes doubled the risk of coronary heart disease and more than doubled the risk of ischemic stroke.² A 50-year-old with diabetes died on average six years earlier than a counterpart without it, and about 40 percent of that gap came from causes other than vascular disease, including several cancers.³ Diabetes is also linked to about 1.5 times the risk of Alzheimer's disease and of dementia overall.⁴

Some of this is reversible. In the DiRECT trial in primary care, 46 percent of people in a structured weight-management program were in remission after a year, against 4 percent with usual care, and the chance of remission rose with the amount of weight lost.⁵

Exercise: Where the Evidence Is Strongest

Exercise is one of the most effective tools you have. In a meta-analysis of 47 randomized trials, structured exercise training lowered HbA1c by about 0.7 percentage points.⁶ In cohort studies of people with diabetes, the most active had 39 percent lower all-cause mortality and 29 percent fewer cardiovascular events than the least active.⁷

Aerobic exercise (150+ min/week) is the base for fitness and glucose control. Timing helps too: in a crossover trial in 41 adults with type 2 diabetes, advice to walk after meals lowered post-meal glucose by 12 percent compared with walking once a day, and by 22 percent after the evening meal.⁸ A short walk after dinner is an easy habit to start with.

Resistance training (2–3 times a week) targets the tissue where insulin resistance begins.¹ In the same exercise meta-analysis, resistance training on its own lowered HbA1c by about 0.6 points.⁶ Prioritize compound movements with progressive overload.

Fitness. In a cohort of men with diabetes, mortality fell steeply as fitness rose: among normal-weight men, the least fit quarter had 6.6 times the mortality of the fittest quarter, with similar gradients in overweight and obese men.⁹ Fitness responds to training at any age.

Nutrition: The Metabolic Framework

No single named diet wins. In PREDIMED, a Mediterranean diet supplemented with extra-virgin olive oil or nuts lowered major cardiovascular events by about 30 percent in older adults at high cardiovascular risk.¹⁰ Low-carbohydrate diets work faster early on: in a meta-analysis of 23 trials, they nearly doubled remission rates at six months (57 vs 31 percent), but data at 12 months were sparse.¹¹

Prioritize protein. Protein at each meal helps protect muscle, keeps you full and has little direct effect on blood glucose, which matters most if you are losing weight.

Manage carbohydrate quality. Fiber-rich carbohydrates (legumes, vegetables, intact whole grains) raise glucose less than refined ones, and responses differ between people: in an 800-person study with continuous glucose monitors, identical meals produced highly variable glucose responses.¹² A short trial of a glucose monitor can show you your own pattern.

Time-restricted eating. In a six-month trial in 75 adults with type 2 diabetes and obesity, eating within an 8-hour window without counting calories lowered weight by about 3.6 percent and HbA1c by about 0.9 points relative to controls, an HbA1c drop no different from daily calorie counting.¹³ Larger, longer trials are still needed.

Testing and Monitoring Beyond HbA1c

Standard diabetes care focuses on HbA1c, but for longevity, you need a broader picture of the aging pathways T2D accelerates.

Fasting insulin and HOMA-IR — HbA1c reflects average glucose but not the insulin resistance behind it. Fasting insulin and HOMA-IR can show whether that is improving. There is no agreed target, so watch your own trend.

ApoB and lipids — Heart disease is the biggest threat in type 2 diabetes,² so lipid treatment matters. ApoB counts the cholesterol-carrying particles directly and is worth adding to a standard panel.

Kidney function (eGFR and UACR) — Diabetes damages the kidneys over time, and albumin in the urine often shows up before eGFR falls, so ask for both tests every year. If kidney disease appears, SGLT2 inhibitors protect the kidneys (see below).

Coronary artery calcium (CAC) score — Because diabetes roughly doubles coronary risk,² a CAC scan can help you and your doctor decide how aggressive to be.

Supplements and Medications with Specific T2D Evidence

Metformin is the long-standing first drug for type 2 diabetes, with decades of safety data. (For the evidence on metformin and aging, see our metformin article.) Long-term use can lower vitamin B12: in the Diabetes Prevention Program follow-up, low or borderline B12 was about twice as common with metformin at five years (19 vs 10 percent), so have B12 checked periodically.¹⁴

SGLT2 inhibitors (empagliflozin, dapagliflozin) — In EMPA-REG OUTCOME, empagliflozin cut cardiovascular death by 38 percent and heart-failure hospitalization by 35 percent in people with type 2 diabetes at high cardiovascular risk.¹⁵ In DAPA-CKD, dapagliflozin lowered the risk of serious kidney decline, kidney failure or death from kidney or cardiovascular causes by 39 percent, with similar effects with or without diabetes.¹⁶

GLP-1 receptor agonists (semaglutide, liraglutide) — In type 2 diabetes, liraglutide (LEADER) and semaglutide (SUSTAIN-6) reduced major cardiovascular events by 13 and 26 percent.^17,18 In SELECT, semaglutide cut events by 20 percent in people with heart disease and overweight or obesity who did not have diabetes, although side effects led more people to stop it (17 vs 8 percent).¹⁹

Berberine — In a 2022 meta-analysis of 37 randomized trials (3,048 patients), berberine lowered HbA1c by about 0.6 points; the trials were mostly small, and many came from Chinese databases.²⁰ Check our Interaction Checker before combining it with prescription drugs, and use it only with medical guidance.

Omega-3 and vitamin D — Trials have not supported routine use. In ASCEND, 1 g a day of omega-3 did not reduce serious vascular events over 7.4 years in people with diabetes.²¹ In D2d, 4,000 IU of vitamin D a day did not significantly reduce progression from prediabetes to diabetes.²² Correct a documented deficiency, but don't count on either for heart protection.